Fc gamma receptors (FcγRs) on immune cells bind the Fc portion of IgG antibodies, translating antibody binding into cellular activation or inhibition. Activating FcγRs contain immunoreceptor tyrosine-based activation motifs (ITAMs) that trigger kinase cascades, while inhibitory FcγRs contain ITIMs that suppress activation. The balance between activating and inhibitory signaling determines the magnitude of immune response.
Map the signaling pathways downstream of FcγR engagement, including Lyn and Syk kinases. Consider how IgG immune complexes and crosslinking enhance signaling.
Not all FcγRs have the same affinity for IgG subclasses—FcγRIII has higher affinity for IgG1 and IgG3. A single FcγR may not trigger strong activation; clustering through immune complex is often required.
You already know that antibodies have two functional ends: the variable Fab region that binds antigen and the constant Fc region that communicates with the rest of the immune system. But how exactly does the Fc region deliver its message? The answer lies in Fc gamma receptors (FcγRs) — a family of cell-surface receptors expressed on macrophages, neutrophils, NK cells, dendritic cells, and other immune cells that specifically recognize the Fc portion of IgG antibodies. These receptors are the molecular translators that convert antibody binding into cellular action.
The FcγR family includes both activating and inhibitory members, and the balance between them determines the outcome of IgG engagement. The activating receptors — FcγRI (CD64), FcγRIIA (CD32A), and FcγRIIIA (CD16A) — contain or associate with immunoreceptor tyrosine-based activation motifs (ITAMs) in their cytoplasmic tails. When IgG-coated targets crosslink multiple activating FcγRs, ITAMs are phosphorylated by Src family kinases (particularly Lyn), creating docking sites for the tyrosine kinase Syk. Syk activation triggers downstream signaling cascades — PLCγ, PI3K, MAPK pathways — that drive phagocytosis, degranulation, cytokine release, or cytotoxicity depending on the cell type. This is the same general signaling logic you learned in receptor signaling pathways, applied specifically to immune cell activation.
The inhibitory receptor FcγRIIB (CD32B) provides a critical counterbalance. It contains an immunoreceptor tyrosine-based inhibitory motif (ITIM) that, when phosphorylated, recruits the phosphatase SHIP-1. SHIP-1 dephosphorylates signaling intermediates generated by the activating receptors, effectively dampening the immune response. This activating-versus-inhibitory balance operates as a threshold mechanism: immune cells respond vigorously when activating signals dominate (many IgG molecules coating a target) but remain quiescent when inhibitory signals prevail (low-level IgG in circulation). This prevents inappropriate activation against the small amounts of IgG normally present in body fluids.
A crucial concept is receptor crosslinking. A single IgG molecule binding a single FcγR generates minimal signaling. Robust activation requires multiple FcγRs to be clustered together, which happens when many IgG molecules are packed closely on a target surface — as occurs when antibodies coat a bacterium or form an immune complex. This clustering requirement acts as a safety mechanism, ensuring that FcγR signaling fires only when antibodies are concentrated on a genuine target rather than floating freely in solution. The different FcγRs also vary in their affinity for IgG subclasses: FcγRI is a high-affinity receptor that can bind monomeric IgG, while FcγRIIA and FcγRIIIA are low-affinity receptors that require immune complexes for effective engagement. These affinity differences, combined with differential expression across cell types, create a finely tuned system where the type of IgG subclass, the density of antibody coating, and the identity of the responding cell all shape the downstream immune response — from gentle phagocytosis to aggressive antibody-dependent cellular cytotoxicity (ADCC).